0 avis
Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: a multicenter, randomized, placebo-controlled, double-blind trial
Archive ouverte : Article de revue
Edité par HAL CCSD ; SAGE Publications
International audience. OBJECTIVE: Our aim was to assess the usefulness of cranberry extract in multiple sclerosis (MS) patients suffering from urinary disorders. METHODS: In total, 171 adult MS outpatients with urinary disorders presenting at eight centers were randomized (stratification according to center and use of clean intermittent self-catheterization) to cranberry versus placebo in a 1-year, prospective, double-blind study that was analyzed using a sequential method on an intent-to-treat basis. An independent monitoring board analyzed the results of the analyses each time 40 patients were assessed on the main endpoint. Cranberry extract (36 mg proanthocyanidins per day) or a matching placebo was taken by participants twice daily for 1 year. The primary endpoint was the time to first symptomatic urinary tract infection (UTI), subject to validation by a validation committee. RESULTS: The second sequential analyses allowed us to accept the null hypothesis (no difference between cranberry and placebo). There was no difference in time to first symptomatic UTI distribution across 1 year, with an estimated hazard ratio of 0.99, 95% CI [0.61, 1.60] (p = 0.97). Secondary endpoints and tolerance did not differ between groups. CONCLUSION: Taking cranberry extract versus placebo twice a day did not prevent UTI occurrence in MS patients with urinary disorders. Trial Registration NCT00280592.
Consulter en ligne
Suggestions
Du même auteur
![Tout l'ECN / [coordination] Jean Lemoine..., Florian Naudet..., Eric Bellissant... | Lemoine, Jean (19..-....) - interne en hématologie. Directeur de publication](https://covers.syracuse.cloud/Cover/BUVPP/MONO/MT7rm01DgVUBiOM4H96Jew2/9782340058583/MEDIUM?fallback=http%3a%2f%2fsyracusepreprod.univ-catholille.fr%2fui%2fskins%2fICTL%2fportal%2ffront%2fimages%2fGeneral%2fDocType%2fMONO_MEDIUM.png "Plus d'infos sur 'Tout l'ECN / [coordination] Jean Lemoine..., Florian Naudet..., Eric Bellissant...'")
Du même sujet
